Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice

The efficacy of many coronavirus disease 2019 (COVID-19) vaccines has been shown to decrease to varying extents against new severe acute respiratory syndrome coronavirus 2 variants, which are responsible for the continuing COVID-19 pandemic. Combining intramuscular and intranasal vaccination routes...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xingxing, Wang, Ling, Liu, Jingjing, Fang, Enyue, Liu, Xiaohui, Peng, Qinhua, Zhang, Zelun, Li, Miao, Liu, Xinyu, Wu, Xiaohong, Zhao, Danhua, Yang, Lihong, Li, Jia, Cao, Shouchun, Huang, Yanqiu, Shi, Leitai, Xu, Hongshan, Wang, Yunpeng, Suo, Yue, Yue, Guangzhi, Nie, Jianhui, Huang, Weijin, Li, Wenjuan, Li, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331206/
https://www.ncbi.nlm.nih.gov/pubmed/35775819
http://dx.doi.org/10.1080/22221751.2022.2097479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331206/
https://www.ncbi.nlm.nih.gov/pubmed/35775819
http://dx.doi.org/10.1080/22221751.2022.2097479

Ejemplares similares